HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vitacost Seeks To Rebrand Site Beyond Supplement Sales

This article was originally published in The Tan Sheet

Executive Summary

The e-commerce firm overhauls its logo and website, adding additional content and products to its inventory of more than 34,000 SKUs, bulking up in categories outside of traditional supplements, including conventional food, personal care and beauty products.

You may also be interested in...



Pfizer Builds Nutrition Site To Grow Vitamin Business

The website nutritionpossible.com is Pfizer’s latest effort to improve its consumer segment, including the Centrum vitamins line. The site also offers a health assessment tool for recommending supplements and lifestyle changes to consumers.

People In Brief

Erykman joins DSM as executive VP

Vitacost.com Turns To Vitamin Shoppe Founder To Right Ship

Vitacost.com CEO Ira Kerker steps down and Jeffrey Horowitz takes the post after logistics challenges and a proxy fight shook up the company's board of directors

Topics

Related Companies

UsernamePublicRestriction

Register

RS125093

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel